J-PAL North America, based at MIT, leads J-PAL’s work in the North America region. J-PAL North America conducts randomized evaluations, builds partnerships for evidence-informed policymaking, and helps partners scale up effective programs.
Our work spans a wide range of sectors including health care, housing, criminal justice, education, and economic mobility. We leverage research by affiliated professors from universities across the continent and a full-time staff of researchers, policy experts, and administrative professionals to generate and disseminate rigorous evidence about which anti-poverty social policies work and why.

More about J-PAL North America
To stay up to date on J-PAL North America's most exciting announcements, stories, and successes, subscribe to our monthly newsletter.
Considering a career at J-PAL North America? Review our Join Our Team brochure to learn more about our work and team culture.

Blog
J-PAL North America Staff Spotlight: Communications & Fundraising Team
This Staff Spotlight highlights three J-PAL North America team members who disseminate research results and encourage relationships with donors, policymakers, implementers, peer organizations, and researchers.

Blog
How government, academic, and nonprofit partners are working to evaluate a home visiting program in South Carolina to improve family health and wellbeing
Jordan Desai (South Carolina Department of Health Human Services) ; William Thorland, (National Service Office for Nurse-Family Partnership and Child First); and Margaret McConnell (Harvard T.H. Chan School of Public Health) discuss the rigorous evaluation of the Nurse-Family Partnership program in...

Blog
Newly published data on health care hotspotting study underscores the importance of research transparency
The team behind the evaluation on health care hotspotting describes why they prioritized publishing replication data and lessons learned from the process.
In the news
Making Medicare, Medicaid innovation tests voluntary undermines evaluation opportunities
Jesse Gubb discusses the importance of randomized evaluations to identify and scale up innovative Medicaid and Medicare payment models.